🩸 Human Blood Fractions & Immunological Products

🌐 HS Code Reference & Customs Clearance Guide | 2024 Latest Tariff Analysis | Professional Compliance Strategy
📌 I. Product Definition & Classification: What Are We Talking About?

Human blood fractions and immunological products are specialized medical commodities derived from human or animal blood. They are prepared for therapeutic, prophylactic, or diagnostic purposes. In international trade, these products are highly regulated due to their biological nature and potential health risks. They generally fall under Chapter 30 of the Harmonized System (HS), specifically within the category of "Antisera, other blood fractions and immunological products."

The classification depends heavily on the form (mixed vs. unmixed) and packaging (measured doses/retail vs. bulk).

⚠️ Key Distinction Points: - 3002.12.00.90: Covers "Other" blood fractions and antisera that are not immunological products in the strict sense (e.g., specific plasma fractions, albumin, globulins) or those not classified as vaccines/toxins/cultures. It captures the broader category of blood derivatives. - 3002.13.00.90: Specifically targets Immunological products (e.g., antibodies, immune sera) that are unmixed, not put up in measured doses, and not in forms/packings for retail sale. This is crucial for bulk pharmaceutical manufacturing.

📦 II. HS Code Classification Details (2024/2025 Tariff Authority Comparison)

🔍 Critical Reminder: - 3002.12.00.90 is a "catch-all" for blood fractions and antisera that don’t fit the stricter "immunological product" definition of 3002.13. It includes most plasma derivatives used for therapy. - 3002.13.00.90 is for pure immunological products (like specific immune globulins) in bulk form (not retail-ready). If these are put up in measured doses (e.g., vials for direct patient use), they may fall under other subheadings (e.g., 3002.90). - Both codes in the provided data show 0% tax, but this is subject to change based on trade agreements and origin.

💰 III. 2024/2025 Latest Tariff Rate Details (Including Additional Duties & Policy Surcharges)

✅ Applicable Country: United States (US)
✅ Country of Origin: China (CN)
✅ Effective Date: Current rates apply (verify for 2024/2025 updates)

🎯 1. 3002.12.00.90 —— Other Blood Fractions & Antisera

📌 Explanation: - The base tariff for most human blood fractions is 0%. - Unlike electronics or steel, biological products under 3002.12 are not subject to the 25% USITC Section 301 duty or the IEEPA 10% surcharge on most Chinese goods, as they are considered essential medical supplies. - However, they are strictly regulated by the FDA. While the tariff may be 0%, the non-tariff barriers (regulatory compliance) are extremely high.

🎯 2. 3002.13.00.90 —— Immunological Products (Bulk)

📌 Note: - Like 3002.12, this code also carries a 0% total tariff. - This applies to unmixed, bulk immunological products. If the product is mixed or in retail form, it may fall under 3002.90 or other codes, which could have different rates. - Zero tariff does not mean zero effort. Regulatory approval (BLA/NDA) is mandatory for importation into the US.

🛠️ IV. Customs Clearance Practical Advice (Battle-Tested Pitfall Avoidance Guide)

✅ 1. Required Documentation Checklist (Non-Negotiable)

📌 Critical Note:
- Even with 0% tariff, customs will hold the shipment if FDA documentation is missing. Delays can cost tens of thousands in cold storage fees.

✅ 2. Declaration Tips (Key Mantras)

🔥 "Biologicals, Not Drugs, FDA First, HS Second!"

✅ 3. Special Cases Handling

🌍 V. Global Market Customs Comparison (2024/2025 Latest)

📌 Conclusion: - Tariff is 0% globally for most blood fractions, but regulatory compliance is the real cost driver. - USA has the most rigorous FDA enforcement. Do not underestimate the paperwork.

📌 VI. Common Mistakes & Pitfalls (Lessons Learned)

❌ Mistake 1: Declaring "Vaccines" when the product is "Blood Fractions"
👉 Consequence: Misclassification → FDA hold + fines.

❌ Mistake 2: Using "De Minimis" for shipments under $800
👉 Consequence: Rejected. Biological products are never eligible for de minimis clearance in the US due to FDA regulations.

❌ Mistake 3: Poor Cold Chain Documentation
👉 Consequence: Product destruction. No amount of correct HS code will save a spoiled biological.

❌ Mistake 4: Ignoring "Animal" vs. "Human" Origin
👉 Consequence: Different FDA pathways (Human vs. Veterinary). Misdeclaration leads to seizure.

✅ Correct Practice:

"Human Albumin, 25%, Solution, Bulk, Non-Retail Form, Stored at 2-8°C, FDA Prior Notice #XXXXX, HTSUS 3002.12.00.90"

🎯 VII. Conclusion: Precision in Regulation, Not Just Tariffs

🎯 Remember the Mantra:

🔹 "0% Tariff ≠ Easy Entry. FDA is King, Cold Chain is Queen."
🔹 "HS Code 3002, Blood Fractions True, Docs Complete, Clearance Won."

📌 Pro Tip:
- Always apply for FDA Prior Notice at least 24 hours in advance. - Use a customs broker with FDA expertise. General brokers may miss biological requirements. - Maintain chain of custody records from factory to port.

📣 Immediate Action:

📞 Contact FDA-registered customs broker + Provide CoA + File Prior Notice
🚀 Ensure your biological products clear customs, stay viable, and reach patients.

✨ Professional Clearance, Starts with Regulatory Precision!
💼 Your Time is Biologically Time-Sensitive!